3 terminated, 2 completed, 1 withdrawn. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 3, Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Cancer of the Prostate: new trials by email Literature Review of Cancer of the Prostate trials Research Report on Cancer of the Prostate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2022-08-05 | |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NUV-422 - Glioma, Glioma, Malignant | Phase 1 | Terminated | Nuvation Bio Inc. | 74 | 2020-12-08 | 2023-07-14 |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer ASN001: Escalating dose Part A - Cancer of the Prostate, Neoplasms, Prostate | Phase 1 | Terminated | Asana BioSciences | 27 | 2015-01-19 | 2018-03-07 |
| Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Anti-OX40, Radiation, Cyclophosphamide - Metastatic Prostate Cancer, Cancer of the Prostate | Phase 1 | Completed | Providence Health & Services | 13 | 2010-10-14 | 2018-08-29 |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer Dendritic cell application - Cancer of the Prostate | Phase 1 / Phase 2 | Completed | Cantonal Hospital of St. Gallen | 15 | 2002-11-01 | 2015-08-17 |
Prostatic Neoplasms (6) · Prostatic Neoplasms, Castration-Resistant (3) · Breast Neoplasms (2) · Glioblastoma (1) · Glioma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Genital Diseases (6) · Genital Diseases, Male (6) · Genital Neoplasms, Male (6) · Male Urogenital Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Prostatic Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Breast Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adnexal Diseases (1) · Astrocytoma (1) · Digestive System Diseases (1)
enzalutamide (2) · Cyclophosphamide (1) · Radiation (1) · olaparib (1)
Nuvation Bio Inc. (3) · Asana BioSciences (1) · Cantonal Hospital of St. Gallen (1) · Providence Health & Services (1)
United States (5) · Australia (1)
Brendan D Curti, MD (1) · Niranjan Rao, PhD (1) · Thomas Cerny, Prof. Dr. (1)